These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 23584693
1. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function. Munk M, Kiss C, Huf W, Sulzbacher F, Bolz M, Sayegh R, Eisenkölbl S, Simader C, Schmidt-Erfurth U. Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693 [Abstract] [Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X, Li J, Hu X, Yu S, Pan J, Tang S. Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [Abstract] [Full Text] [Related]
3. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M. Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967 [Abstract] [Full Text] [Related]
4. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema. Acharya NR, Sittivarakul W, Qian Y, Hong KC, Lee SM. Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165 [Abstract] [Full Text] [Related]
5. Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Kumar N, Marsiglia M, Mrejen S, Fung AT, Slakter J, Sorenson J, Freund KB. Retina; 2013 Sep; 33(8):1605-12. PubMed ID: 23549101 [Abstract] [Full Text] [Related]
6. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes. Reddy AK, Cabrera M, Yeh S, Davis JL, Albini TA. Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857 [Abstract] [Full Text] [Related]
7. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA. Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [Abstract] [Full Text] [Related]
8. Association between foveal microstructure and visual outcome in age-related macular degeneration. Shin HJ, Chung H, Kim HC. Retina; 2011 Sep; 31(8):1627-36. PubMed ID: 21606888 [Abstract] [Full Text] [Related]
9. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results. Dunavoelgyi R, Sacu S, Eibenberger K, Palkovits S, Leydolt C, Pruente C, Schmidt-Erfurth U. Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958 [Abstract] [Full Text] [Related]
10. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes. Baek JS, Cho HJ, Cho SW, Kim CG, Kim JW. Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082 [Abstract] [Full Text] [Related]
11. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K. Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456 [Abstract] [Full Text] [Related]
12. Refractive changes after pharmacologic resolution of diabetic macular edema. Deák GG, Lammer J, Prager S, Mylonas G, Bolz M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group Vienna. Ophthalmology; 2014 May; 121(5):1054-8. PubMed ID: 24439462 [Abstract] [Full Text] [Related]
13. Reading speed improvements in retinal vein occlusion after ranibizumab treatment. Suñer IJ, Bressler NM, Varma R, Lee P, Dolan CM, Ward J, Colman S, Rubio RG. JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977 [Abstract] [Full Text] [Related]
14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH, Lee CS, Lee SC. Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [Abstract] [Full Text] [Related]
15. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema. Rahimi M, Shahrzad SS, Banifatemi M. Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801 [Abstract] [Full Text] [Related]
16. One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment. Munk MR, Kiss C, Huf W, Sulzbacher F, Roberts P, Mittermüller TJ, Sacu S, Simader C, Schmidt-Erfurth U. Am J Ophthalmol; 2013 Oct; 156(4):633-43. PubMed ID: 23891335 [Abstract] [Full Text] [Related]
17. Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. Munk MR, Ram R, Rademaker A, Liu D, Setlur V, Chau F, Schmidt-Erfurth U, Goldstein DA. Acta Ophthalmol; 2015 Nov; 93(7):e561-7. PubMed ID: 25708777 [Abstract] [Full Text] [Related]
18. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA. Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244 [Abstract] [Full Text] [Related]
19. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Lim JW, Lee HK, Shin MC. Ophthalmologica; 2012 Feb; 227(2):100-6. PubMed ID: 21997197 [Abstract] [Full Text] [Related]
20. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab. Jeon S, Lee WK. Retina; 2014 Aug; 34(8):1606-11. PubMed ID: 24553409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]